Mario León Silva-Vergara; Mareio R. Pineli; Marcos C. Galati; Dalmo Correia
RESUMO
Dois pacientes com síndrome de imunodeficiência adquirida (SIDA) desenvolveram psoríase, um com quadro mais grave e outro com apresentação mais benigna, sendo tratados com zidovudine na dose oral de 200mg a cada oito horas. No primeiro caso, a resposta terapêutica foi completa e, após nove meses em esquema de manutenção, o paciente se apresenta sem nenhuma lesão. No segundo, a despeito de resposta evidente, após seis meses de tratamento, o paciente ainda apresenta descamação furfurãcea a nível dos membros inferiores, mesmo em uso de medicação.
Palavras-chaves: SIDA. HIV. Psoríase. AZT.
ABSTRACT
Two patients with the acquired immunodeficiency syndrome (AIDS) developed psoriasis, one of them presenting the more severe form and the other one the milder form of the disease, were treated with zidovudine per oral via, 200mg 3 times a day. In the first case the therapeutical response was complete. No lesion was verified in the patient after 9 months under maintenance schedule. In the second case, despite the response being clear, after 6 months of treatment, the patient still presented furfuraceous scalings at limbs even under the medication schedule.
Keywords: AIDS. HIV. Psoriasis. AZT.
Texto completo disponível apenas em PDF.
Full text available only in PDF format.
REFERÊNCIAS BIBLIOGRÁFICAS
1. Cotone C, Lucentini M, Garcia G, Molina A. Psoriasis y leucoencefalopatia multifocal progresiva en el SIDA. Revista clinica espanhola 191:285-286,1992. [ Links ]
2. Cristopher E, Krueger GG. Psoriasis, hi: Fitzpatrick B, Eisen Z,Auton K,Wolff K, Freedberg M (eds) Dermatology General iMedicine, McGraw Hill, New York, 3rd edition, vol 1, chapter 42, p 461-491,1987. [ Links ]
3. Domonkos AN. Dermatitis seborreica y Psoriasis. In: Andrews (ed) Tratado de dermatologia, segunda edición, Salvat ed, Barcelona, chapter 10, p. 228-242,1975. [ Links ]
4. Duvic M Johnson TM, Rapini RP Freese T, Brewton G, Rios A. Acquired immunodeficiency syndrome- associated psoriasis and Reiter’s syndrome. Archives Dermatology 23:1622-1632,1987. [ Links ]
5. Duvic M. Immunology of AIDS related to psoriasis.The journal of investigative dermatology 95:38S-40S, 1990. [ Links ]
6. Farber E, Nall L. Psoriasis associated with human immunodeficiency virus/acquired immunodeficiency sindrome.Cutis 52: 29-35,1993. [ Links ]
7. Honeyman J. SIDA. Dermatologia (Chile) 7: 99- 101,1991 [ Links ]
8. Johnson MT, Duvic M, Rapini RP, Rios A. AIDS exacerbates psoriasis (correspondence). The New England Journal of Medicine 313:1415, 1985. [ Links ]
9. Maugée E, Aractingi S. Dermatoses erythemato- squameuses. Psoriasis et pityriasis rubra pilaire. In: Piérard GE, Caumes E, Franchimont C, Estrada JA (eds) Dermatologie Tropicale, Université de Bruxelles, chapitre 45, p. 467-476,1993. [ Links ]
10. Obuch M, Maurer T, Becker B, Berger T. Psoriasis and human immunodeficiency virus infection. Journal of the American Academy of Dermatology 27:667-673,1992. [ Links ]
11. Pillsbury DM, Heapton CL. Papulosquamous eruptions and connective tissue diseases- psoriasis. In: Manual of dermatology, WB Saunders Company, 2nd edition, chapter 9, p – 136- 139,1980. [ Links ]
12. Reveille J, Conant M, Duvic M. Human immunodeficiency virus-associated psoriasis, Psoriatic arthritis and Reiter’s Sindrome: a disease continuum? Arthritis and Rheumatism 33:1574- 1578,1990. [ Links ]
13. Sadick N, McNutt N, Kaplan M. Papulosquamous dermatoses of AIDS. Journal of the American Academy of Dermatology 22:1272-1274,1990. [ Links ]
14. Safai B, Schwartz J. Noninfections organ-specific complications of HTV ‘ infection. Dermatologie complications. In: Devita Jr V, Hillman S, Uosemberg S (eds) AIDS-Etiology, Diagnosis, Treatment, and Prevention. 3rd Edition J.B. Lippincott Company, Philadelphia, p.313-319, 1992. [ Links ]
15. Zalla M, Daniel Su W, Fransway A. Dermatologie manifestations of human immunodeficiency virus infection. Mayo Clinic Proceedings 67: 1089-1108,1992. [ Links ]
Recebido para publicação em 26/06/95.
Endereço para correspondência:
Prof. Mario León Silva-Vergara.
DIP/FMTM, Caixa Postal 118, 38001-970, Uberaba, MG.
Tel.: (034) 312-7722, r: 1255 e 1285.
Fax: (034) 312-7722 r: 1279
